Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M18,011Revenue (TTM) $M19,693Net Margin (%)-54.8Altman Z-Score-0.1
Enterprise Value $M50,854EPS (TTM) $-10.9Operating Margin %17.7Piotroski F-Score2
P/E(ttm)--Beneish M-Score-2.7Pre-tax Margin (%)-63.1Higher ROA y-yN
Price/Book1.310-y EBITDA Growth Rate %--Quick Ratio0.6Cash flow > EarningsY
Price/Sales0.95-y EBITDA Growth Rate %--Current Ratio0.9Lower Leverage y-yN
Price/Free Cash Flow5.1y-y EBITDA Growth Rate %--ROA % (ttm)-15.1Higher Current Ratio y-yN
Dividend Yield %0.5PEG--ROE % (ttm)-55.1Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M1,019ROIC % (ttm)5.9Gross Margin Increase y-yN

Gurus Latest Trades with TEVA

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
Current Price Change from Average Comment Current Shares

TEVA is held by these investors:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History

TEVA: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Fridriksdottir HafrunExecutive VP, Global R&D 2018-11-30Sell933$21.76-18.89view
McClellan Michael JamesEVP, CFO 2018-11-05Sell346$22.73-22.35view
O'Grady Brendan P.EVP, North America Commercial 2018-09-18Sell1,241$23.71-25.56view
Nazzi GianfrancoEVP, Growth Markets Commercial 2018-09-18Sell1,379$23.69-25.5view
Griffin Deborah AChief Accounting Officer 2018-09-18Sell2,376$23.71-25.56view
Dethlefs SvenEVP Global Marketing&Portfolio 2018-09-18Sell625$23.71-25.56view
Daniell RichardExec. VP, European Commercial 2018-09-18Sell2,488$23.69-25.5view
Daniell RichardExec. VP, European Commercial 2018-09-10Sell696$21.25-16.94view
Codner Iris BeckEVP Global Brand&Communication 2018-08-09Sell4,165$22.7-22.25view
Dethlefs SvenEVP Global Marketing&Portfolio 2018-08-03Buy2,000$21.92-19.48view

Quarterly/Annual Reports about TEVA:

    News about TEVA:

    Articles On GuruFocus.com
    A Pharmaceutical Company With a Resilient Portfolio and Solid Pipeline Nov 29 2018 
    Detailed Research: Economic Perspectives on American Tower Corporation (REIT), Ligand Pharmaceutical Nov 29 2018 
    Financial Results Spur 2 Stocks Higher on Thursday Nov 01 2018 
    New Research: Key Drivers of Growth for Teva Pharmaceutical Industries, Axovant Sciences, SolarEdge Oct 19 2018 
    5 Asian Stocks Gurus Agree On Sep 24 2018 
    Chris Portfolio Sep 14 2018 
    Teva, NACHC and Direct Relief Provide Important Insights on Prescription Medicine Access for Underse Sep 06 2018 
    Bernard Horn’s Top 3 Buys in 2nd Quarter Sep 04 2018 
    Watch Aug 29 2018 
    Pharma Aug 28 2018 
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

    GF Chat